Minimal Hepatic Encephalopathy in Children: Evaluation with Proton MR Spectroscopy

References

1. ↵
   1. Stewart CA,
   2. Reivich M,
   3. Lucey MR,
   4. et al

   . Neuroimaging in hepatic encephalopathy. Clin Gastroenterol Hepatol 2005; 3: 197– 207

   CrossRefPubMed
2. ↵
   1. Mattarozzi K,
   2. Stracciari A,
   3. Vignatelli L,
   4. et al

   . Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. Arch Neurol 2004; 61: 242– 47

   CrossRefPubMed
3. ↵
   1. Mechtcheriakov S,
   2. Graziadei IW,
   3. Mattedi M,
   4. et al

   . Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl 2004; 10: 77– 83

   CrossRefPubMed
4. ↵
   1. Stewart SM,
   2. Hiltebeitel C,
   3. Nici J,
   4. et al

   . Neuropsychological outcome of pediatric liver transplantation. Pediatrics 1991; 87: 367– 76

   Abstract/FREE Full Text
5. ↵
   1. Gitlin N,
   2. Lewis DC,
   3. Hinkley L

   . The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3: 75– 82

   CrossRefPubMedWeb of Science
6. ↵
   1. Loguercio C,
   2. Del Vecchio-Blanco C,
   3. Coltorti M

   . Psychometric tests and “latent” portal-systemic encephalopathy. Br J Clin Pract 1984; 38: 407– 11

   PubMed
7. ↵
   1. Watanabe A

   . Cerebral changes in hepatic encephalopathy. J Gastroenterol Hepatol 1998; 13: 752– 60

   PubMed
8. ↵
   1. Stewart CA,
   2. Smith GE

   . Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 677– 85

   PubMed
9. ↵
   1. Kreis R,
   2. Ross BD,
   3. Farrow NA,
   4. et al

   . Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 19– 27

   PubMedWeb of Science
10. ↵
    1. Ross BD,
    2. Danielsen ER,
    3. Bluml S

    . Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 1996; 14 Suppl 1: 30– 39

    CrossRefPubMed
11. ↵
    1. Ross BD,
    2. Jacobson S,
    3. Villamil F,
    4. et al

    . Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193: 457– 63

    PubMedWeb of Science
12. ↵
    1. Binesh N,
    2. Huda A,
    3. Thomas MA,
    4. et al

    . Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 2006; 7: 86– 96

    CrossRefPubMed
13. ↵
    1. Naegele T,
    2. Grodd W,
    3. Viebahn R,
    4. et al

    . MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000; 216: 683– 91

    PubMedWeb of Science
14. ↵
    1. Thomas MA,
    2. Huda A,
    3. Guze B,
    4. et al

    . Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy. AJR Am J Roentgenol 1998; 171: 1123– 30

    PubMed
15. ↵
    1. Sijens PE,
    2. Alkefaji H,
    3. Lunsing RJ,
    4. et al

    . Quantitative multivoxel (1)H MR spectroscopy of the brain in children with acute liver failure. Eur Radiol 2008; 18: 2601– 09

    CrossRefPubMed
16. ↵
    1. Provencher SW

    . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672– 79

    CrossRefPubMedWeb of Science
17. ↵
    1. Campollo O,
    2. Sprengers D,
    3. McIntyre N

    . The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics. Rev Invest Clin 1992; 44: 513– 18

    PubMed
18. ↵
    1. Dejong CH,
    2. van de Poll MC,
    3. Soeters PB,
    4. et al

    . Aromatic amino acid metabolism during liver failure. J Nutr 2007; 137 ( issue>6 Suppl 1): 1579S– 85S; discussion 97S – 98S

    Abstract/FREE Full Text
19. ↵
    1. Haussinger D,
    2. Laubenberger J,
    3. vom Dahl S,
    4. et al

    . Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 1475– 80

    PubMedWeb of Science
20. ↵
    1. Lee JH,
    2. Seo DW,
    3. Lee YS,
    4. et al

    . Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 1999; 94: 2206– 13

    CrossRefPubMed
21. ↵
    1. Haussinger D,
    2. Kircheis G,
    3. Fischer R,
    4. et al

    . Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000; 32: 1035– 38

    CrossRefPubMedWeb of Science
22. ↵
    1. Huda A,
    2. Guze BH,
    3. Thomas A,
    4. et al

    . Clinical correlation of neuropsychological tests with 1H magnetic resonance spectroscopy in hepatic encephalopathy. Psychosom Med 1998; 60: 550– 56

    Abstract/FREE Full Text
23. ↵
    1. Cooper AJ,
    2. Mora SN,
    3. Cruz NF,
    4. et al

    . Cerebral ammonia metabolism in hyperammonemic rats. J Neurochem 1985; 44: 1716– 23

    CrossRefPubMedWeb of Science
24. ↵
    1. Zwingmann C

    . Nuclear magnetic resonance studies of energy metabolism and glutamine shunt in hepatic encephalopathy and hyperammonemia. J Neurosci Res 2007; 85: 3429– 42

    CrossRefPubMed
25. ↵
    1. Zwingmann C,
    2. Butterworth R

    . An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy. Neurochem Int 2005; 47: 19– 30

    CrossRefPubMedWeb of Science
26. ↵
    1. Stewart SM,
    2. Uauy R,
    3. Kennard BD,
    4. et al

    . Mental development and growth in children with chronic liver disease of early and late onset. Pediatrics 1988; 82: 167– 72

    Abstract/FREE Full Text
27. ↵
    1. Krull K,
    2. Fuchs C,
    3. Yurk H,
    4. et al

    . Neurocognitive outcome in pediatric liver transplant recipients. Pediatr Transplant 2003; 7: 111– 18

    CrossRefPubMedWeb of Science
28. ↵
    1. Taylor-Robinson SD,
    2. Sargentoni J,
    3. Marcus CD,
    4. et al

    . Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994; 9: 347– 59

    CrossRefPubMedWeb of Science
29. ↵
    1. Köstler H

    . Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 291– 301

    CrossRefPubMed
30. ↵
    1. Pouwels PJ,
    2. Brockmann K,
    3. Kruse B,
    4. et al

    . Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999; 46: 474– 85

    CrossRefPubMedWeb of Science